© Siemens

The continued sharp decline in demand for rapid coronavirus antigen tests is weighing on Siemens Healthineers' Diagnostics business. Order intake fell from €6.1 billion in the third quarter of 2022 to €5.6 billion in the past quarter. On a comparable basis, revenue increased by 4% from €5.19 billion to €5.20 billion. The higher earnings are attributable to the Imaging and Advanced Therapies businesses.